Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
PaperCitations, authors & open-access status
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,035 citations, 2014 year and closed oa status.
1,035
Citations
2014
Year
closed
OA Status